These four new awards bring the total of stratified medicine consortia funded by the MRC to thirteen with investment totalling over £52 million – part of the government’s £130 million commitment to stratified medicine set out in the UK Life Sciences Strategy.

To read the whole article please click here.

The post Minister announces £14m investment in stratified medicine appeared first on AIM HY .

To read the whole article please click here.

The post Latest blood pressure research appeared first on AIM HY .

Parties who believe that they could make a valuable contribution to these short-listed proposals are invited to contact the relevant teams.

The nine short-listed applications for full proposals are in asthma, cancer, hypertension, the lung condition idiopathic pulmonary fibrosis, lupus, a kidney disease called nephrotic syndrome and transplantation.

For the full article click here.

The post Stratified medicine initiative: short-listed proposals to second call for disease focused-consortia appeared first on AIM HY .

High blood pressure, or hypertension, is common in the general population. A healthy lifestyle alone is not enough to control blood pressure, and drug treatment is required.

There are a wide variety of drugs available and although these are effective and safe, it is often necessary to try different types of drugs and often to use a combination of two or more drugs.

For the full article click here.

The post Delving deep into ancestry to help doctors prescribe better hypertension treatments appeared first on AIM HY .

We have committed over a £1 million to the £3.5 million AIM HY study, which is being led by researchers at King’s College London. The study is one of four stratified medicine initiatives being funded in collaboration with the Medical Research Council (MRC).

For the full article click here.

The post BHF: Our million pound boost for blood pressure research appeared first on AIM HY .